Janux Therapeutics
JANX
JANX
57 hedge funds and large institutions have $354M invested in Janux Therapeutics in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 16 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3.16% more ownership
Funds ownership: 72.94% → 76.1% (+3.2%)
2% less capital invested
Capital invested by funds: $362M → $354M (-$8.13M)
Holders
57
Holding in Top 10
–
Calls
$24K
Puts
$4K
Top Buyers
| 1 | +$13.3M | |
| 2 | +$13M | |
| 3 | +$4.99M | |
| 4 |
O
OrbiMed
New York
|
+$4.85M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
+$4.77M |
Top Sellers
| 1 | -$5.37M | |
| 2 | -$723K | |
| 3 | -$520K | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$422K |
| 5 |
Millennium Management
New York
|
-$379K |